Survivin is not a promising serological maker for the diagnosis of hepatocellular carcinoma

Author：

E-ISSN： 1792-1082|9|5|2347-2352

ISSN： 1792-1074

Source： Oncology Letters, Vol.9, Iss.5, 2015-01, pp. : 2347-2352

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Survivin overexpression in hepatocellular carcinoma is associated with p53 dysregulation

By Kannangai Rajesh Wang Jianzhou Liu Qiong Sahin Fikret Torbenson Michael

International Journal of Gastrointestinal Cancer, Vol. 35, Iss. 1, 2005-02 ,pp. : 53-60

Humana Press, Inc

Access to resources Recommend Favorite

Survivin depletion inhibits tumor growth and enhances chemosensitivity in hepatocellular carcinoma

Molecular Medicine Reports, Vol. 10, Iss. 4, 2014-01 ,pp. : 2025-2030

Spandidos Publications

Access to resources Recommend Favorite

Expressions of Survivin and Caspase-3 in human hepatocellular carcinoma and the relationship with prognosis

By Ding Wei Hu Wei Wang Xiyan Dong Xiaogang

The Chinese-German Journal of Clinical Oncology, Vol. 9, Iss. 11, 2010-11 ,pp. : 628-632

Springer Publishing Company

Access to resources Recommend Favorite

Expression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinoma

International Journal of Oncology, Vol. 47, Iss. 6, 2015-01 ,pp. : 2208-2216

Spandidos Publications

Access to resources Recommend Favorite

Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma

By Sun Yulin

Carcinogenesis, Vol. 34, Iss. 3, 2013-03 ,pp. : 595-604

Oxford University Press

Access to resources Recommend Favorite